Akanda
Akanda · page 3
- Adult-Use
European Cannabis Stocks Review: Akanda Signs With Cookies, IM Cannabis Sees Slight Recovery, & Futura Medical Prepares For FDA Approval
Markets across Europe opened lower this morning as ongoing and increasingly severe reports of a looming economic crisis pushed the FTSE 100, German DAX, French CAC 40 and the pan-European Stoxx 600 into the red.
- Press releases
Akanda To Supply Cansativa With Premium Indoor Cannabis Flower Grown At Its Sintra Facility In Portugal
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen.
- Adult-Use
Akanda Could Lose Its African Subsidiary Bophelo Amid Dispute With Former Executive Chairman
AKANDA’s wholly owned subsidiary Bophelo Bioscience, which operates the company’s key cultivation facility in Lesotho, has been taken into liquidation by the country’s high court in what the company is calling a ‘retaliation’ from a disgruntled former director.
- Adult-Use
European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill Brands
It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress on cannabis liberalisation.
- Markets & Stocks
European Cannabis Stocks Review: SEED Innovations Shares Spike 25%, Futura Medical Signs Commercialisation Deal, & More From Akanda
AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable week compared to their North American counterparts, with both Canadian and US indexes experiencing swings in both directions.
- Markets & Stocks
EU Cannabis Stocks Review: Board Changes At Kanabo & Cellular Goods, Panaxia Stages Comeback & Akanda Continues Rally
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.
- News
UK Cannabis Firm Akanda’s US Listing Sees Value Skyrocket As It Unveils Plans To ‘Put Capital To Work’
AKANDA Corp has become the latest British cannabis company to go public after it launched on the NASDAQ Stock Exchange this week, seeing its stock soar some 350% above its listing price.
- Press releases
Akanda Corp. Names Dr. Sunny Nayee as U.K. Medical Director to Support Partnership With Cellen Life Sciences
At Akanda, Dr. Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
- Press releases
Akanda Corp Closes $5m Private Placement
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000.
- Press releases
Halo Collective Readies Akanda For A Senior Exchange Listing By Entering Into A Share Purchase Agreement
HALO Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced that it has entered into an agreement (“the Agreement”) with Akanda Corp. (“Akanda”) in connection with the previously announced sale of its international assets (the “Transaction”).
- Medical
New UK Spin-Out Looks To Europe With Its African-Grown Medical Cannabis Flowers
ONE of the UK’s newest medical cannabis companies is set to launch its own medicine in a move which will see it become the latest vertically-integrated market player.
